episode-header-image

Jul 2

23m 52s

MS Research Briefs: MRI Biomarkers, Mach...

The European Committee for Treatment and Research in Multiple Sclerosis

About this episode

Up next

How Technology Is Transforming Multiple Sclerosis Care

Technology is opening new possibilities for how multiple sclerosis is monitored, treated and managed. In this episode of the ECTRIMS Podcast, host Brett Drummond speaks with Prof. Ellen Mowry of Johns Hopkins University and Prof. Letizia Leocani of Vita-Salute San Raffaele Univer ... Show More

Should High-Risk Populations Be Screened for Multiple Sclerosis?

Could multiple sclerosis one day be detected before symptoms appear? And if so, should we be actively screening people who are at higher risk? In this episode of the ECTRIMS–MS Journal collaboration series, host Prof. Anneke van der Walt, Controversies Editor at the Multiple Scle ... Show More

How Geography, Healthcare Systems and Access Shape the Multiple Sclerosis Journey

Where someone lives can profoundly influence their multiple sclerosis journey. While advances in diagnosis and treatment have transformed MS care in many parts of the world, millions of people still face significant barriers to diagnosis, specialist care and life-changing therapi ... Show More

Recommended Episodes

Depression in Multiple Sclerosis

Dr. Nara Michaelson starts a series discussing the less obvious ways that Multiple Sclerosis impacts the lives of patients and how neurologists can address these challenges and support patients.

Multiple Sclerosis (MS)

Send us Fan MailThis week, Rob and Zach will be talking about Multiple Sclerosis (MS).We will be discussing the following topics within this episode on MS!Introduction / Types of Multiple SclerosisCauses / PathophysiologyClinical FeaturesPhysical Exam FindingsDiagnosisTreatmentTo ... Show More

Multiple Sclerosis and Family Planning

Dr. Shuvro Roy talks with Dr. Riley Bove about managing patients with multiple sclerosis as they navigate family planning and pregnancy. Read the related article in Neurology: Clinical Practice. Disclosures can be found at Neurology.org.

MS Talks 2.0 Episode 3: An Emotional Rollercoaster: How To Divert From The Road?

MS Talks 2.0 is a collaboration between Lovin Dubai and Novartis. The 10-episode series brings together experts and members of the community to bring awareness to Multiple Sclerosis.In this episode, we attempt to navigate the difficult journey of diagnosis under the guidance of M ... Show More

Guidelines on disease-modifying treatment in MS: a decade-long update

The latest guidelines on disease-modifying treatment in multiple sclerosis (MS) from the Association of British Neurologists is discussed in this intercontinental podcast with perspectives from the UK, the USA, and Australia. Participants: <ul> <li>Professor Alasdair Coles is H ... Show More

MS TALKS 2.0: What MS Is Not

MS Talks 2.0. Let's Discuss Facts. A series brought to you by Novartis, where we discuss the topic of multiple sclerosis. With special guests, of experts and members of the community, we're bringing awareness to MS with the aim to normalise the conversation. There are many misc ... Show More

Ep 92 Multiple Sclerosis: Scarred nerves & skating saints

Like many autoimmune diseases, multiple sclerosis so clearly illustrates how detection and description of a disease only gets us so far when it comes to prevention, treatment, and cure. In the over 150 years since the first comprehensive description of multiple sclerosis, a great ... Show More

Multiple Sclerosis

<p>In this episode I cover multiple sclerosis.<br/><br/>If you want to follow along with written notes on multiple sclerosis go to <a href='https://zerotofinals.com/medicine/neurology/ms/'>https://zerotofinals.com/medicine/neurology/ms/</a> or the neurology section in the Zero to ... Show More

Hematopoietic Stem Cell Transplant in Secondary Progressive MS

Welcome to MS Research Briefs, a new ECTRIMS podcast series delivering an expert guided tour of important new studies in multiple sclerosis research.

In each episode, leading MS experts will take a small number of recently published studies and go beyond the headline findings – exploring what the research shows and how it may influence clinical practice and future discovery.

In this inaugural episode, Prof. Alan Thompson and Prof. Olga Ciccarelli discuss two studies exploring how advanced MRI biomarkers and machine learning may transform the diagnosis and prognosis of multiple sclerosis.

Featured Publications

Paramagnetic Rim Lesions and Development of Clinical MS in Radiologically Isolated Syndrome.
JAMA Neurology. 2026;83(3):250–258.
Machine learning-based combination of the central vein sign, cortical lesions and paramagnetic rim lesions: a web-based tool for the diagnosis of multiple sclerosis.
Brain Communications. 2026;8(2):fcag079.

Discussed in this episode

Can paramagnetic rim lesions identify individuals with radiologically isolated syndrome (RIS) who are most likely to develop clinical MS?
Why do paramagnetic rim lesions appear to be stronger prognostic biomarkers while the central vein sign remains a powerful diagnostic biomarker?
Can machine learning models combining MRI biomarkers outperform traditional dissemination-in-space criteria?
What role might advanced MRI biomarkers play in future diagnostic criteria and treatment decisions?
How close are we to AI-supported diagnosis and automated biomarker detection in routine clinical practice?

As advanced MRI biomarkers move from research tools towards clinically meaningful decision-making, this episode explores one of the most important developments in contemporary MS research.

--------------------------------

This ECTRIMS podcast episode is supported by an educational grant from Alexion, AstraZeneca Rare Diseases. Bristol Myers Squibb, Novartis, Roche, Sanofi, and UCB. Educational grant providers have no input into the podcast series content.